Cerro Pacific Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-3,112
Closed -$268K – 171
2025
Q1
$268K Sell
3,112
-189
-6% -$15.6K 0.09% 137
2024
Q4
$393K Buy
3,301
+828
+33% +$89.5K 0.13% 117
2024
Q3
$353K Hold
2,473
– – 0.13% 115
2024
Q2
$353K Buy
+2,473
New +$328K 0.14% 115

Other funds holding NVO

Cerro Pacific Wealth Advisors's NVO Position: Q2 2025 in Review

Cerro Pacific Wealth Advisors sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,112 shares — an estimated $268K sold.

Cerro Pacific Wealth Advisors first reported a position in NVO in Q2 2024 and held it in 4 quarters. The position peaked at $393K in Q4 2024. 1,484 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Cerro Pacific Wealth Advisors reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Cerro Pacific Wealth Advisors sold 3,112 Novo Nordisk shares in Q2 2025, an estimated $268K.
  • Cerro Pacific Wealth Advisors first reported a position in Novo Nordisk in Q2 2024 and held it in 4 quarters.
  • Cerro Pacific Wealth Advisors's Novo Nordisk position peaked at $393K in Q4 2024.
  • 1,484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.